An Up-to-Date Description of the Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Italy: Evidence from Real Clinical Practice

The analysis showed that patients prescribed with NSAIDs were relatively young (~ 60 years), in contrast with the pathologies covered by Note 66, which typically affect elderly people. Moreover, rheumatic and oncological diseases were poorly represented, thus it is possible that NSAIDs might have been prescribed for indications outside the note. These findings suggest that the use of NSAIDs for pain management in Italy should be optimized, properly weighting their risks and benefits.

Authors

Institutions

Publication Details

Journal
Advances in Therapy
Published
2025-03-19
DOI
https://doi.org/10.1007/s12325-025-03153-3
Citations
4
Primary Topic
Inflammatory mediators and NSAID effects
Type
article
Field-Weighted Citation Impact
5.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Up-to-Date Description of the Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Italy: Evidence from Real Clinical Practice

Valentina Perrone, Chiara Veronesi, Domenico Lucatelli, Luca Degli Esposti et al.
4 citations
Advances in Therapy
Inflammatory mediators and NSAID effects
5.58
article

An Up-to-Date Description of the Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Italy: Evidence from Real Clinical Practice

Valentina Perrone, Chiara Veronesi, Domenico Lucatelli, Luca Degli Esposti, Andrea Luciani, Maria Ciappetta
article en
4 citations

Abstract

The analysis showed that patients prescribed with NSAIDs were relatively young (~ 60 years), in contrast with the pathologies covered by Note 66, which typically affect elderly people. Moreover, rheumatic and oncological diseases were poorly represented, thus it is possible that NSAIDs might have been prescribed for indications outside the note. These findings suggest that the use of NSAIDs for pain management in Italy should be optimized, properly weighting their risks and benefits.

Advances in TherapyVol. 42(5)
Angelini Pharma (Italy) (IT)
Angelini Pharma
Good health and well-being
Openalex Percentile: Top 5%
Inflammatory mediators and NSAID effects
5.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.